Cartrophen Vet 100 mg/ml Solution for Injection.
Cartrophen Vet 100 mg/ml Solution for Injection.
Authorised
- Pentosan polysulfate sodium
Product identification
Medicine name:
Cartrophen Vet 100 mg/ml Solution for Injection.
Active substance:
- Pentosan polysulfate sodium
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Pentosan polysulfate sodium100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AX90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- A clear, colourless to slightly yellow, aqueous solution contained in a 10 ml Ph.Eur. Type I clear glass vial fitted with a 20 mmbromobutyl rubber stopper and closed by a plastic flip off seal attached to an aluminium seal.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Maperath Herbal Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Arthropharm (Ireland) Limited
- Eurovet Animal Health B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22748/001/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 2/03/2025
